These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26855563)

  • 1. High-dose OxyContin to treat pain associated with bone metastasis in patients with small-cell lung cancer: a case study report.
    Zhou T; Zhang X; Dong Y; Zhuang F; Jiang F; Yu J; Zhang B
    Drug Des Devel Ther; 2016; 10():383-7. PubMed ID: 26855563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose controlled-release oxycodone in hospice care.
    Bercovitch M; Adunsky A
    J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical observations on safety and efficacy of OxyContin® administered by rectal route in treating cancer related pain.
    Li CG; Huang XE; Li Y; Lu YY
    Asian Pac J Cancer Prev; 2011; 12(10):2477-8. PubMed ID: 22320941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
    Yu SY;
    Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of vaginal administration of controlled-release oxycodone on cancer pain].
    Zhang X; Ruan XJ; Liu C; Yu ZH
    Ai Zheng; 2009 Jul; 28(7):740-2. PubMed ID: 19624902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful management of a patient with pain and dyspnea from bone metastasis and lymphangitis carcinomatosa after surgery for non-small cell lung cancer (NSCLC) in whom optimal dosages of transdermal fentanyl were determined by titration with fentanyl injection, and oxycodone hydrochloride].
    Gika M; Eguchi K; Inoue Y; Izawa N; Takeuchi K; Nakayama M
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):547-50. PubMed ID: 20332702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.
    Suzuki T; Morishita M; Ito E; Matsuura M; Tanaka R; Saito T
    Am J Ther; 2008; 15(1):31-5. PubMed ID: 18223351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
    Cicero TJ; Inciardi JA; Muñoz A
    J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
    Ackerman SJ; Mordin M; Reblando J; Xu X; Schein J; Vallow S; Brennan M
    J Manag Care Pharm; 2003; 9(3):223-31. PubMed ID: 14613465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial.
    Sima L; Fang WX; Wu XM; Li F
    J Clin Pharm Ther; 2012 Feb; 37(1):27-31. PubMed ID: 21208247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled-release oxycodone hydrochloride (OxyContin).
    Heidrich DE
    Clin Nurse Spec; 2001 Sep; 15(5):207-9. PubMed ID: 11855610
    [No Abstract]   [Full Text] [Related]  

  • 13. Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: a pilot assessment of the CoDem protocol.
    Samolsky Dekel BG; Tomasi M; Vasarri A; Gori A; Adversi M; Castagnoli A; Di Nino G; Melotti RM
    J Opioid Manag; 2014; 10(1):29-38. PubMed ID: 24604567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral oxycodone: new preparation. No better than oral morphine.
    Prescrire Int; 2003 Jun; 12(65):83-4. PubMed ID: 12825566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninterventional observational study using high-dose controlled-release oxycodone (CR oxycodone) for cancer pain management in outpatient clinics.
    Baek SK; Shin HW; Choi YJ; Zang DY; Cho DY; Ryoo HM; Baek JH; Kim SY; Song HS
    Pain Med; 2013 Dec; 14(12):1866-72. PubMed ID: 24010556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis.
    Lazzari M; Greco MT; Marcassa C; Finocchi S; Caldarulo C; Corli O
    Drug Des Devel Ther; 2015; 9():5863-72. PubMed ID: 26586937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized nursing and therapeutic effect of oxycontin on oral mucosal pain in nasopharyngeal carcinoma patients.
    Hu W; Chen L; Wang C; Guo L; Hua X; Cai Y; Fan Y
    J Cancer Res Ther; 2018; 14(7):1594-1599. PubMed ID: 30589045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.
    Hanna M; O'Brien C; Wilson MC
    Eur J Pain; 2008 Aug; 12(6):804-13. PubMed ID: 18262450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.